{
    "Trade/Device Name(s)": [
        "AllTest Multi-Drug Rapid Test Cup",
        "AllTest Multi-Drug Rapid Test Cup Rx",
        "AllTest Multi-Drug Rapid Test Panel",
        "AllTest Multi-Drug Rapid Test Panel Rx"
    ],
    "Submitter Information": "Hangzhou AllTest Biotech Co.,Ltd.",
    "510(k) Number": "K233019",
    "Predicate Device Reference 510(k) Number(s)": [
        "K182738"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DKZ",
        "NFT",
        "DIS",
        "JXM",
        "DJG",
        "PTH",
        "DIO",
        "DJR",
        "NFV",
        "LAF",
        "DJC",
        "LDJ",
        "NGL",
        "NFY",
        "DNK",
        "LCM",
        "PTG",
        "LFG",
        "NGG",
        "NFW",
        "NGI",
        "NGM",
        "QAW"
    ],
    "Summary Letter Date": "September 21, 2023",
    "Summary Letter Received Date": "September 22, 2023",
    "Submission Date": "November 3, 2023",
    "Regulation Number(s)": [
        "21 CFR 862.3100",
        "21 CFR 862.3150",
        "21 CFR 862.3170",
        "21 CFR 862.3250",
        "21 CFR 862.3620",
        "21 CFR 862.3610",
        "21 CFR 862.3870",
        "21 CFR 862.3640",
        "21 CFR 862.3650",
        "21 CFR 862.3910"
    ],
    "Regulation Name(s)": [
        "Amphetamine Test System",
        "Barbiturate Test System",
        "Benzodiazepines Test System",
        "Cocaine and metabolites Test System",
        "Methadone Test System",
        "Methamphetamine Test System",
        "Cannabinoids Test System",
        "Morphine Test System",
        "Opiate Test System",
        "Tricyclic Antidepressant Drugs Test System"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Amphetamine",
        "Buprenorphine",
        "Secobarbital",
        "Benzodiazepines",
        "Cocaine",
        "2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP)",
        "Methamphetamine",
        "Methylenedioxymethamphetamine (MDMA)",
        "Morphine",
        "Methadone",
        "Oxycodone",
        "Phencyclidine",
        "Nortriptyline",
        "Marijuana (THC)"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [
        ""
    ],
    "Instrument(s)/Platform(s)": [
        ""
    ],
    "Method(s)/Technology(ies)": [
        "Competitive binding",
        "Lateral flow immunochromatographic assay"
    ],
    "Methodologies": [
        "Immunochromatographic",
        "Antigen-antibody immunochemistry"
    ],
    "Submission Type(s)": [
        "Kit",
        "Panel",
        "Cup"
    ],
    "Document Summary": "FDA 510(k) summary for AllTest Multi-Drug Rapid Test Cup and Panel for qualitative detection of drugs of abuse and their metabolites in urine using competitive binding lateral flow immunochromatographic technology.",
    "Indications for Use Summary": "For qualitative and simultaneous detection of Amphetamine, Buprenorphine, Secobarbital, Benzodiazepines, Cocaine, EDDP, Methamphetamine, MDMA, Morphine, Methadone, Oxycodone, Phencyclidine, Nortriptyline, and Marijuana in human urine; intended for in vitro diagnostic OTC and prescription use, providing preliminary results for drugs of abuse screening.",
    "fda_folder": "Toxicology"
}